Vanguard Group’s Indaptus Therapeutics INDP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-256,265
| Closed | -$141K | – | 4304 |
|
|
2025
Q1 | $141K | Hold |
256,265
| – | – | ﹤0.01% | 4102 |
|
|
2024
Q4 | $216K | Hold |
256,265
| – | – | ﹤0.01% | 4095 |
|
|
2024
Q3 | $318K | Hold |
256,265
| – | – | ﹤0.01% | 4067 |
|
|
2024
Q2 | $543K | Hold |
256,265
| – | – | ﹤0.01% | 3979 |
|
|
2024
Q1 | $574K | Hold |
256,265
| – | – | ﹤0.01% | 3981 |
|
|
2023
Q4 | $451K | Buy |
256,265
+5,517
| +2% | +$9.71K | ﹤0.01% | 4072 |
|
|
2023
Q3 | $691K | Buy |
250,748
+400
| +0.2% | +$1.1K | ﹤0.01% | 3958 |
|
|
2023
Q2 | $478K | Hold |
250,348
| – | – | ﹤0.01% | 4131 |
|
|
2023
Q1 | $463K | Hold |
250,348
| – | – | ﹤0.01% | 4141 |
|
|
2022
Q4 | $363K | Buy |
250,348
+101
| +0% | +$146 | ﹤0.01% | 4183 |
|
|
2022
Q3 | $541K | Buy |
250,247
+3,300
| +1% | +$7.13K | ﹤0.01% | 4190 |
|
|
2022
Q2 | $645K | Buy |
246,947
+4,712
| +2% | +$12.3K | ﹤0.01% | 4219 |
|
|
2022
Q1 | $969K | Buy |
242,235
+38,216
| +19% | +$153K | ﹤0.01% | 4218 |
|
|
2021
Q4 | $1.16M | Buy |
204,019
+128,178
| +169% | +$731K | ﹤0.01% | 4223 |
|
|
2021
Q3 | $594K | Buy |
+75,841
| New | +$594K | ﹤0.01% | 4357 |
|